Sarepta Therapeutic (SRPT) PT Cut to $16 at Baird on Dsappointing 168 Week Data
Tweet Send to a Friend
Baird analyst Brian Skorney lowered his price target on Sarepta Therapeutic (NASDAQ: SRPT) to $16.00 (from $21.00) while reiterating an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
